Relugolix kombinovaná terapie a symptomy děložní myomatózy - vybrané kazuistiky indikačního spektra a výsledků léčby

Title in English Relugolix combination therapy and symptoms of uterine myomatosis – selected case reports of indication spectrum and treatment outcomes
Authors

HUDEČEK Robert KLAT J. POHL K. PROKOPENKO A. MIKULASEK L. ŠIMOVÁ Soňa KRCAL P. SEVCIK A. TOMES P.

Year of publication 2023
Type Article in Periodical
Magazine / Source CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY
MU Faculty or unit

Faculty of Medicine

Citation
Web https://www.prolekare.cz/casopisy/ceska-gynekologie/2023-5-6/relugolix-kombinovana-terapie-a-symptomy-delozni-myomatozy-vybrane-kazuistiky-indikacniho-spektra-a-vysledku-lecby-135551
Doi http://dx.doi.org/10.48095/cccg2023359
Keywords relugolix combination therapy; uterine fibroid symptoms
Description Objective: An illustrative review of the indications for relugolix combination therapy (RCT) in the management of symptoms associated with uterine myomatosis. Methods: A set of annotated case reports from outpatient and clinical practice. Results: The file includes a non-invasive methodology for defining excessive menstrual bleeding using the pictorial bleeding assessment chart (PBAC). It also presents the use of RCT as a fertility-sparing procedure prior to elective myomectomy and the management of isthmic fibroids as an uterine factor of infertility. Cases of RCT of adenomyosis in primary sterility and in extragenital forms of endometriosis are commented. Emergent events associated with complications of myomatosis in pregnancy are represented by a case report of necrotizing diff use myomatosis in puerperium. The differential-diagnostic confusion of adnexal pathology and myomatosis, RCT as a final solution to failed pharmacotherapy, and the alternative of hysterectomy in premenopause illustrate the diverse spectrum of indications for pharmacological treatment, including the possibility of dual therapy with RCT and aGnRH. Conclusion: Relugolix combination therapy as an effective and safe causal treatment expands the therapeutic spectrum and options for reproductive medicine specialists and registering gynaecologists. The availability of conservative treatment in combination with surgical treatment leads to optimalization and greater effectiveness of therapeutic procedures and increased quality of life for women with myomatosis.

You are running an old browser version. We recommend updating your browser to its latest version.

More info